Scholarly Index
Chi‐Ho Lee
Astellas Pharma (United States); 9,144 total citations; 441 total publications; best world rank #118
Astellas Pharma (United States)
9,144Total citations
441Total publications
52H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Liver Disease Diagnosis and Treatment | 2021-2025 | 582 | US 133 | 97.42 |
| COVID-19 Clinical Research Studies | 2021-2025 | 964 | US 217 | 96.16 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 161 | US 48 | 94.69 |
| Diabetes Treatment and Management | 2021-2025 | 431 | US 152 | 95.41 |
| Thyroid Disorders and Treatments | 2021-2025 | 118 | US 21 | 92.32 |
| Diabetes and associated disorders | 2021-2025 | 347 | US 139 | 92.83 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 242 | US 48 | 88.98 |
| Diet, Metabolism, and Disease | 2021-2025 | 804 | US 138 | 83.11 |